103 related articles for article (PubMed ID: 22953786)
21. Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial.
Tendera M; Wojakowski W; Ruzyłło W; Chojnowska L; Kepka C; Tracz W; Musiałek P; Piwowarska W; Nessler J; Buszman P; Grajek S; Breborowicz P; Majka M; Ratajczak MZ;
Eur Heart J; 2009 Jun; 30(11):1313-21. PubMed ID: 19208649
[TBL] [Abstract][Full Text] [Related]
22. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease.
Heeschen C; Lehmann R; Honold J; Assmus B; Aicher A; Walter DH; Martin H; Zeiher AM; Dimmeler S
Circulation; 2004 Apr; 109(13):1615-22. PubMed ID: 15037527
[TBL] [Abstract][Full Text] [Related]
23. Randomized controlled trials on the therapeutic effects of adult progenitor cells for myocardial infarction: meta-analysis.
Jiang M; He B; Zhang Q; Ge H; Zang MH; Han ZH; Liu JP; Li JH; Zhang Q; Li HB; Jin Y; He Q; Gong XR; Yin XY
Expert Opin Biol Ther; 2010 May; 10(5):667-80. PubMed ID: 20384520
[TBL] [Abstract][Full Text] [Related]
24. Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease.
Richards M; Nicholls MG; Espiner EA; Lainchbury JG; Troughton RW; Elliott J; Frampton CM; Crozier IG; Yandle TG; Doughty R; MacMahon S; Sharpe N; ;
J Am Coll Cardiol; 2006 Jan; 47(1):52-60. PubMed ID: 16386664
[TBL] [Abstract][Full Text] [Related]
25. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
Bonanno C; Ometto R; Pasinato S; Finocchi G; La Vecchia L; Fontanelli A
Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900
[TBL] [Abstract][Full Text] [Related]
26. Physical training in patients with chronic heart failure of ischemic origin: effect on exercise capacity and left ventricular remodeling.
Klecha A; Kawecka-Jaszcz K; Bacior B; Kubinyi A; Pasowicz M; Klimeczek P; Banyś R
Eur J Cardiovasc Prev Rehabil; 2007 Feb; 14(1):85-91. PubMed ID: 17301632
[TBL] [Abstract][Full Text] [Related]
27. Bone Marrow Stem Cell Treatment for Ischemic Heart Disease in Patients with No Option of Revascularization: A Systematic Review and Meta-Analysis.
Fisher SA; Dorée C; Brunskill SJ; Mathur A; Martin-Rendon E
PLoS One; 2013; 8(6):e64669. PubMed ID: 23840302
[TBL] [Abstract][Full Text] [Related]
28. Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy.
Perin EC; Dohmann HF; Borojevic R; Silva SA; Sousa AL; Silva GV; Mesquita CT; Belém L; Vaughn WK; Rangel FO; Assad JA; Carvalho AC; Branco RV; Rossi MI; Dohmann HJ; Willerson JT
Circulation; 2004 Sep; 110(11 Suppl 1):II213-8. PubMed ID: 15364865
[TBL] [Abstract][Full Text] [Related]
29. Cell therapy for heart failure: the need for a new therapeutic strategy.
Povsic TJ; O'Connor CM
Expert Rev Cardiovasc Ther; 2010 Aug; 8(8):1107-26. PubMed ID: 20670189
[TBL] [Abstract][Full Text] [Related]
30. Effect of intramyocardial bone marrow cell injection on left ventricular dyssynchrony and global strain.
van Ramshorst J; Atsma DE; Beeres SL; Mollema SA; Ajmone Marsan N; Holman ER; van der Wall EE; Schalij MJ; Bax JJ
Heart; 2009 Feb; 95(2):119-24. PubMed ID: 18198204
[TBL] [Abstract][Full Text] [Related]
31. Transendocardial autologous bone marrow mononuclear cell injection in ischemic heart failure: postmortem anatomicopathologic and immunohistochemical findings.
Dohmann HF; Perin EC; Takiya CM; Silva GV; Silva SA; Sousa AL; Mesquita CT; Rossi MI; Pascarelli BM; Assis IM; Dutra HS; Assad JA; Castello-Branco RV; Drummond C; Dohmann HJ; Willerson JT; Borojevic R
Circulation; 2005 Jul; 112(4):521-6. PubMed ID: 16027258
[TBL] [Abstract][Full Text] [Related]
32. Randomized, double-blind pilot study of transendocardial injection of autologous aldehyde dehydrogenase-bright stem cells in patients with ischemic heart failure.
Perin EC; Silva GV; Zheng Y; Gahremanpour A; Canales J; Patel D; Fernandes MR; Keller LH; Quan X; Coulter SA; Moore WH; Herlihy JP; Willerson JT
Am Heart J; 2012 Mar; 163(3):415-21, 421.e1. PubMed ID: 22424012
[TBL] [Abstract][Full Text] [Related]
33. A comparative analysis of short- and long-term outcomes after ventricular fibrillation out-of-hospital cardiac arrest in patients with ischemic and nonischemic heart disease.
Bunch TJ; Kottke TE; Lopez-Jimenez F; Mahapatra S; Elesber AA; White RD
Am J Cardiol; 2006 Oct; 98(7):857-60. PubMed ID: 16996862
[TBL] [Abstract][Full Text] [Related]
34. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis.
Abdel-Latif A; Bolli R; Tleyjeh IM; Montori VM; Perin EC; Hornung CA; Zuba-Surma EK; Al-Mallah M; Dawn B
Arch Intern Med; 2007 May; 167(10):989-97. PubMed ID: 17533201
[TBL] [Abstract][Full Text] [Related]
35. Improvement of cardiac function after transplantation of autologous bone marrow mesenchymal stem cells in patients with acute myocardial infarction.
Chen SL; Fang WW; Qian J; Ye F; Liu YH; Shan SJ; Zhang JJ; Lin S; Liao LM; Zhao RC
Chin Med J (Engl); 2004 Oct; 117(10):1443-8. PubMed ID: 15498362
[TBL] [Abstract][Full Text] [Related]
36. Intracoronary administration of autologous bone marrow mononuclear cells after induction of short ischemia is safe and may improve hibernation and ischemia in patients with ischemic cardiomyopathy.
Blatt A; Cotter G; Leitman M; Krakover R; Kaluski E; Milo-Cotter O; Resnick IB; Samuel S; Gozal D; Vered Z; Slavin S; Shapira MY
Am Heart J; 2005 Nov; 150(5):986. PubMed ID: 16290982
[TBL] [Abstract][Full Text] [Related]
37. Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial).
Mathiasen AB; Jørgensen E; Qayyum AA; Haack-Sørensen M; Ekblond A; Kastrup J
Am Heart J; 2012 Sep; 164(3):285-91. PubMed ID: 22980293
[TBL] [Abstract][Full Text] [Related]
38. Five-year follow-up after transepicardial implantation of autologous bone marrow mononuclear cells to ungraftable coronary territories for patients with ischaemic cardiomyopathy.
Akar AR; Durdu S; Arat M; Kilickap M; Kucuk NO; Arslan O; Kuzu I; Ozyurda U
Eur J Cardiothorac Surg; 2009 Oct; 36(4):633-43. PubMed ID: 19524451
[TBL] [Abstract][Full Text] [Related]
39. Intracoronary autologous bone marrow stem cells transfer for patients with acute myocardial infarction: a meta-analysis of randomised controlled trials.
Zhang SN; Sun AJ; Ge JB; Yao K; Huang ZY; Wang KQ; Zou YZ
Int J Cardiol; 2009 Aug; 136(2):178-85. PubMed ID: 18644638
[TBL] [Abstract][Full Text] [Related]
40. Effects of fish oil supplementation on cardiac function in chronic heart failure: a meta-analysis of randomised controlled trials.
Xin W; Wei W; Li X
Heart; 2012 Nov; 98(22):1620-5. PubMed ID: 22760864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
